science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.0703350 on November 21, 2003

Published online before print November 21, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0703350v1
75/3/553    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goral, J.
Right arrow Articles by Kovacs, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goral, J.
Right arrow Articles by Kovacs, E. J.
(Journal of Leukocyte Biology. 2004;75:553-559.)
© 2004 by Society for Leukocyte Biology

Acute ethanol exposure inhibits macrophage IL-6 production: role of p38 and ERK1/2 MAPK

Joanna Goral*,{dagger},{ddagger}, Mashkoor A. Choudhry{dagger},{ddagger},§,1 and Elizabeth J. Kovacs*,{dagger},{ddagger},§,2

Departments of
* Cell Biology, Neurobiology and Anatomy and
§ Surgery,
{dagger} Burn and Shock Trauma Institute, and
{ddagger} Alcohol Research Program, Loyola University Medical Center, Maywood, Illinois

2 Correspondence: Professor Departments of Cell Biology, Neurobiology and Anatomy and Surgery, Loyola University Medical Center, Building 110, Room 4237, 2160 South First Avenue, Maywood, IL 60153. E-mail: ekovacs{at}lumc.edu


arrow
ABSTRACT
 
Acute ethanol consumption has been linked to an increase in infectious complications in trauma and burn patients. Ethanol modifies production of a variety of macrophage-derived immunoregulatory mediators. Lipopolysaccharide (LPS), a potent stimulator of inflammatory responses in macrophages, activates several intracellular signaling pathways, including mitogen-activated protein kinases (MAPK). In the current study, we investigated the effect of acute ethanol exposure on in vivo activation of p38 and extracellularly regulated kinases 1 and 2 (ERK1/2) MAPK in murine macrophages and the corresponding, LPS-stimulated interleukin (IL)-6 production. We demonstrated that a single dose of ethanol transiently down-regulated p38 and ERK1/2 activation levels (3–24 h after treatment) and impaired IL-6 synthesis. Ethanol-related reduction in IL-6 production was not further affected by the presence of inhibitors of p38 and ERK1/2 (SB 202190 and PD 98059, respectively). These results demonstrate that acute ethanol exposure can impair macrophage IL-6 production and indicate that this effect may result from ethanol-induced alterations in intracellular signaling through p38 and ERK1/2.

Key Words: lipopolysaccharide • inflammation • signal transduction • suppression


arrow
INTRODUCTION
 
Ethanol (alcohol) has been recognized as an important immunomodulatory factor. Acute and chronic ethanol consumption is associated with a weakened immune response and with increased susceptibility to bacterial or viral infections. Acute ethanol exposure has been linked to a rise in infectious complications in trauma and burn patients [1 2 3 ], whereas chronic alcohol abuse can exacerbate morbidity and mortality following various infections, including pneumonia [4 , 5 ] and hepatitis C [6 ]. Moreover, alterations in immune function are recognized among symptoms of ethanol-induced hangover in which manifestation persists long after blood ethanol levels are no longer detectable [7 ].

Increased susceptibility to infections and higher risk of complications are secondary to the inhibitory effect of ethanol consumption on cell-mediated and humoral immune responses [8 , 9 ]. Chronic ethanol use has been associated with an increase in circulating, proinflammatory cytokines such as tumor necrosis factor {alpha} (TNF-{alpha}), interleukin (IL)-1, and IL-6 [10 11 12 ]. In contrast, acute ethanol exposure, in vivo and in vitro, has been shown to reduce proinflammatory cytokine synthesis in response to pathogenic stimuli [13 14 15 16 17 ]. Acute ethanol treatment adversely affects the functions of macrophage and other antigen-presenting cells [16 , 18 19 20 ]. Because of the central role of macrophages in innate and adaptive immune responses, ethanol-induced, functional alterations in these cells could have further consequences on immunity, such as contributing to aberrant recognition of antigens and to abnormal cell-mediated and humoral immune responses.

It has been demonstrated that members of the mitogen-activated protein kinase (MAPK) family, among them p38 and extracellularly regulated kinases 1 and 2 (ERK1/2), are involved in innate immune responses [21 ]. p38 preferentially responds to inflammation and stress factors [21 , 22 ]; ERK1/2 is activated by growth and differentiation signals, including growth factors, cytokines, and viral infection [23 24 25 ]. Lipopolysaccharide (LPS)-induced activation of nuclear factor (NF)-{kappa}B [26 ] as well as MAPK [24 , 27 , 28 ] results in the release of multiple cytokines, including TNF-{alpha}, IL-1, IL-6, IL-10, and IL-12 [29 , 30 ]. In addition, MAPK, in particular p38 and ERK1/2 MAPK, is involved in regulation of NF-{kappa}B-dependent gene expression [31 , 32 ]. As ethanol-induced suppression of proinflammatory cytokine production was associated with inhibition of NF-{kappa}B activation [33 ], we hypothesized that p38 and ERK1/2 MAPK activation in macrophages is also affected by ethanol and plays a role in ethanol-mediated inhibition of LPS-induced inflammatory responses.

In the present study, we examined the effect of in vivo acute ethanol exposure on p38 and ERK1/2 MAPK activation and the corresponding effect on LPS-stimulated IL-6 production in murine macrophages.


arrow
MATERIALS AND METHODS
 
Animals
Nine- to 10-week old, 20–24 g, male C57BL/6 mice (Harlan, Indianapolis, IN) were used in all experiments. Mice were acclimated for 1 week upon arrival at the animal facilities of Loyola University Medical Center (Maywood, IL). The studies described here were performed in accordance with the guidelines established by the Loyola University Chicago Institutional Animal Care and Use Committee.

Ethanol administration
Mice were randomly divided into two groups. The first group received an intraperitoneal (i.p.) injection of 150 µl saline; the second group was injected i.p. with 150 µl 20% v/v ethanol in saline, which after 30 min, resulted in 100 mg/dl (22 mM, 1.5 g/kg) circulating ethanol levels [34 , 35 ], the legal limit of blood ethanol levels in many states. This dose of ethanol made mice somewhat lethargic, with only a mild impairment in balance and coordination. Previous studies demonstrated that 24 h after administration, ethanol is not detectable in circulation [3 ]. Administration (i.p.) of ethanol did not result in the local inflammation, as the percentages of macrophages (87.9±3% vs. 87.6±4%) and neutrophils (6±1.7% vs. 7.5±4%) among mononuclear cells collected by peritoneal lavage 3 h after treatment and stained with Wright-Giemsa stain (HEMA 3®, Fisher Scientific Co., Pittsburgh, PA) were similar between control and ethanol-treated mice.

Cell isolation and culture
Mice were killed at 24 and 48 h after ethanol or saline exposure. Purified splenic macrophages were obtained from spleen cell suspensions by plastic adherence. Briefly, 250 µl spleen cells (1.0x107 cells per milliliter) in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) were plated in each well of 96-well microtiter plate. The cells were cultured for 2 h at 37°C with 5% CO2. After the incubation, nonadherent cells were removed by triple wash with warm medium. This method resulted in ~2 x 105 macrophages per well that were more than 98% positive for Mac-3 and Di-I-acetylated, low-density lipoprotein uptake, as shown by this laboratory previously [36 ]. Purified macrophages were cultured in RPMI 2% FBS at 37°C, 5% CO2, in the presence or absence of LPS from Escherichia coli 0111:B4 (100 ng/ml; Sigma Biosciences, St. Louis, MO). In addition, inhibitors of p38 MAPK (SB 202190, 10 µM) or ERK1/2 MAPK (PD 98059, 50 µM; Calbiochem® EMD Biosciences, Darmstadt, Germany) [37 ] were added to the cultures. As SB 202190 and PD 98059 were initially dissolved in dimethyl sulfoxide (DMSO) and then diluted in culture medium, appropriately diluted DMSO vehicle controls were included. After 16 h of incubation, cell supernatants were harvested and frozen at –80°C for later evaluation of IL-6 content. Cells (95–98%) were viable, as confirmed by trypan blue exclusion.

Measurement of IL-6
A commercially available enzyme-linked immunosorbent assay kit (Endogen, Cambridge, MA) assessed the concentrations of IL-6 in splenic macrophage supernatants, according to the manufacturer’s instructions. The maximal IL-6 levels in different experiments ranged between 1200 and 2000 pg/ml; the minimal IL-6 detection level of this assay was 25 pg/ml.

Cell extracts preparation
For the measurement of MAPK phosphorylation levels, mice were killed at 3, 12, 24, and 48 h after ethanol or saline administration. To obtain purified macrophages, the cell-culture protocol was modified. Single-cell suspensions of splenocytes were plated in the six-well plates (1.5x107 cells per well). After 2 h incubation and the removal of nonadherent cells, the remaining adherent cells (98% macrophages) were cultured for 30 min in the presence or absence of 100 ng/ml LPS. At the end of the LPS-stimulation period, the cells were washed twice with phosphate-buffered saline and lysed with 100 µl/106 cells of ice-cold lysis buffer (150 mM NaCl, 1 mM MgCl2, 50 mM HEPES, 1 mM EDTA, 0.5% Triton X-100, 10% glycerol, 200 µM sodium orthovanadate, 100 mM sodium fluoride, 10 mM sodium pyrophosphate, 200 µM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, 0.15 U/ml aprotinin) for 30 min at 4°C [38 ]. Cell lysates were centrifuged at 12,000 g for 10 min at 4°C. Supernatants were stored at –80°C until further analysis. Protein content was assessed by Lowry’s method with a commercially available kit (Sigma Biosciences).

Western blot analysis
Cell extracts (20 µg protein per lane) and p38 or ERK1/2 MAPK control-cell extracts, phosphorylated and nonphosphorylated (Cell Signaling Technology, Beverly, MA), were electrophoretically separated on 7.5% sodium dodecyl sulfate-polyacrylamide gels, as described previously [39 ]. Proteins were electroblotted to PolyScreen membranes (DuPont Systems NEN, Boston, MA) at 200 mA for 1 h as described previously [40 ]. Blots were then blocked for 2 h at room temperature with 5% nonfat dry milk in 50 mM Tris-HCl (pH 7.5), 200 mM NaCl, Tris-buffered saline, 0.05% Tween 20 (TBST). After three 10 min washes with TBST, membranes were incubated overnight at 4°C with antibodies to phospho-p38 MAPK (Thr180/Tyr182), phospho-p44/42 (phospho-ERK1/2) MAPK (Thr202/Tyr204), nonphosphorylated p38 MAPK, and p44/42 (ERK1/2) MAPK (Cell Signaling Technology), diluted 1:1000. After subsequent washes with TBST, 1 h of incubation with peroxidase-conjugated sheep anti-rabbit secondary antibody, diluted 1:5000 (Sigma Biosciences), followed. Antibodies were diluted in 1% bovine serum albumin (Sigma Biosciences) in TBST. Membranes were developed with an enhanced chemiluminescence (ECL) reagent (Amersham Pharmacia Biotech UK, Buckinghamshire) followed by exposure to HyperfilmTM ECLTM (Amersham Pharmacia Biotech UK). After the film was developed, Western blots were evaluated by densitometric analysis using Ambis optical imaging system (Ambis Systems, San Diego, CA).

Statistical analysis
Data were expressed as mean ± SEM of each group. Data were analyzed by ANOVA, followed by post-hoc testing by Fisher’s protected least significant difference test. A P value of <0.05 was considered significant.


arrow
RESULTS
 
Effect of acute ethanol treatment on IL-6 production by murine macrophages
To test the effect of acute ethanol treatment on IL-6 production by macrophages, mice were injected with a dose of ethanol designed to elevate blood concentration to 100 mg/dl, 30 min after administration. After 1 h, blood ethanol levels were at ~40 mg/dl, and after 4 and 8 h, ethanol was not detectable in the circulation (data not shown). Macrophages from ethanol and saline (control group)-treated mice were isolated after 3, 24, or 48 h, and their spontaneous and LPS-induced IL-6 production were compared. We have previously shown that acute ethanol exposure 24 h before thermal injury suppressed immune responses, as manifested by a decrease in delayed-type hypersensitivity and an increase in mortality upon bacterial challenge [3 ]. Moreover, it was reported that blood monocytes collected 16 h after ethanol administration showed a decrease in IL-1ß production in response to ex vivo bacterial stimulation [16 ]. Thus, we presumed that immunomodulatory effects, as a part of an ethanol-induced hangover, will persist at 24 h; however, considering the transient nature of ethanol effects, it would not be detectable 48 h after the treatment. Unstimulated cells failed to produce IL-6 regardless of ethanol exposure; LPS treatment resulted in robust production of the cytokine in all groups. The acute ethanol exposure diminished the ability of macrophages, isolated 3 and 24 h after the treatment, to produce IL-6. LPS-induced IL-6 levels were lowered to ~50% of control by ethanol (Fig. 1 ). This result suggests that even a moderate dose of ethanol can affect the ability of macrophages to respond to the inflammatory challenge. The inhibitory effect of ethanol administration was temporary, as LPS-induced IL-6 production was at the control levels in macrophages isolated 48 h after the treatment (Fig. 1) .



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Ethanol inhibits LPS-induced IL-6 production in macrophages, which were isolated from mice 3, 24, and 48 h after a single i.p. administration of saline (control) or ethanol. Cells were stimulated with 100 ng/ml LPS for 16 h, after which supernatants were assayed for IL-6. A minimum of six animals per group was analyzed. ANOVA, followed by Fisher’s Latin square design (LSD) test, was applied to compare values between the groups. *, P < 0.05, from LPS-stimulated, control group. IL-6 was not detected in cell supernatants in the absence of LPS treatment.

Effect of ethanol administration on activation of p38 and ERK1/2
To evaluate activation levels of p38 and ERK1/2, we used dual, phospho-specific antibodies that bind only to the activated forms of these enzymes. Phosphorylation of p38 and ERK1/2 was detected in freshly isolated macrophages in the absence of LPS stimulation (Fig. 2 ). It was not surprising, as transitory cell activation can result from adherence to polystyrene [41 ]. Moreover, it was reported that adherence of macrophages leads to ERK1/2 activation and primes for LPS-induced TNF-{alpha} production [42 ]. It is interesting that the adherence-induced baseline phosphorylation of p38 and ERK1/2 was significantly suppressed in the cells isolated from ethanol-treated mice compared with control cells (Fig. 2) . In a similar experiment, we found that ethanol treatment had no effect on the basal levels of phosphorylated inhibitor of I{kappa}B (data not shown). This differential effect of ethanol on MAPK and I{kappa}B adherence-induced baseline activation indicated that down-regulation of p38 and ERK1/2 was specific and did not result from a toxicity of ethanol.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 2. Acute ethanol exposure inhibits p38 and ERK1/2 phosphorylation in macrophages. Macrophages were isolated 24 h post-administration of saline (control) or ethanol. The cell extracts were analyzed by Western blot with antibodies (Ab) against phosphorylated p38 (A) or against phosphorylated ERK1/2 (B). The analysis of macrophages isolated from three saline (control)- and three ethanol-treated mice is shown. Densitometric analysis of blots from eight mice per group was performed. t-Test was applied to compare control and ethanol groups. *, P < 0.05, from unstimulated, control group. Data represent results from the analysis of eight animals per group. The same blots were redeveloped with control p38 or ERK1/2 antibodies, detecting total cellular levels of endogenous p38 or ERK1/2 MAPKs. OD, Optical density.

The inhibitory effect of ethanol on IL-6 production corresponded with a down-regulation of p38 and ERK1/2. To evaluate duration of this ethanol-induced effect, we examined phosphorylation levels of p38 and ERK1/2 in macrophages obtained from mice at different time points after ethanol administration. The baseline phosphorylation of p38 and ERK1/2 was reduced to 50–70% of control at 3 and 24 h. After 48 h, p38 and ERK1/2 phosphorylation returned to the control levels (Fig. 3 ).



View larger version (55K):
[in this window]
[in a new window]
 
Figure 3. Duration of ethanol inhibition of p38 and ERK1/2 phosphorylation in macrophages, which were isolated at 0, 3, 24, and 48 h post-administration of saline (control) or ethanol. The cell extracts were prepared from adherent cells and analyzed by Western blot with antibodies against phosphorylated p38 or against phosphorylated ERK1/2. ODs of cell extracts from ethanol-treated animals are expressed as percentages of ODs of cell extracts from control animals at the corresponding time points. A minimum of three animals per group was analyzed. ANOVA, followed by Fisher’s LSD test, was applied to compare values among multiple groups. *, P < 0.05, from 0 and 48 h ethanol-treated groups.

Effect of ethanol administration on LPS-induced phosphorylation of p38 and ERK1/2 MAPK
As LPS was used to stimulate IL-6 production by macrophages, we examined whether ethanol-induced inhibition of IL-6 production resulted from the impaired phosphorylation of p38 and ERK1/2 in response to LPS. Thus, we compared LPS-induced activation of p38 and ERK1/2 in macrophages isolated from mice 24 h after saline or ethanol administration. Macrophages from both groups responded to LPS stimulation by increased phosphorylation of p38 and ERK1/2 (Figs. 4 and 5 ). In both groups, LPS activated p38 by ~50% and ERK1/2 by ~100%. However, as the baseline activation of p38 and ERK1/2 was lower in macrophages from ethanol-treated mice, a corresponding difference following LPS stimulation was maintained. Thus, phosphorylation levels of p38 and ERK1/2 MAPK in LPS-stimulated macrophages from ethanol-treated mice remained lower than in the control group.



View larger version (50K):
[in this window]
[in a new window]
 
Figure 4. Acute ethanol exposure inhibits LPS-stimulated p38 phosphorylation in macrophages, which were isolated 24 h post-administration of saline or ethanol. The cells were stimulated in vitro with LPS (100 ng/ml) for 30 min. Activation of p38 in the cells was analyzed by Western blot with antibody to phosphorylated p38; the analysis of macrophages isolated from two saline (control)- and two ethanol-treated mice is shown. Densitometric analysis of blots from eight mice per group was performed. ANOVA, followed by Fisher’s LSD test, was applied to compare values among four groups. *, P < 0.05, from unstimulated control and LPS-stimulated ethanol groups; **, P < 0.01, from all other groups. The same blots were redeveloped with control p38 antibody, detecting total cellular levels of endogenous p38.



View larger version (56K):
[in this window]
[in a new window]
 
Figure 5. Acute ethanol exposure inhibits LPS-stimulated ERK1/2 phosphorylation in macrophages, which were isolated 24 h post-administration of saline or ethanol. The cells were stimulated in vitro with LPS (100 ng/ml) for 30 min. Activation of ERK1/2 in the cells was analyzed by Western blot with antibody to phosphorylated ERK1/2; the analysis of macrophages isolated from two saline (control)- and two ethanol-treated mice is shown. Densitometric analysis of blots from eight mice per group was performed. ANOVA, followed by Fisher’s LSD test, was applied to compare values among four groups. *, P < 0.05, from unstimulated control and LPS-stimulated ethanol groups; **, P < 0.01, from all other groups. The same blots were redeveloped with control ERK1/2 antibody, detecting total cellular levels of endogenous ERK1/2.

Effects of ethanol and inhibitors of p38 (SB 202190) and ERK1/2 (PD 98059) MAPK on macrophage LPS-induced IL-6 production
To further ascertain the role of p38 and ERK1/2 in the suppression of IL-6 production in ethanol-treated mice, we determined whether inhibition of p38 and ERK1/2 further potentiates the suppression of IL-6. To accomplish this, macrophages were isolated from control and ethanol-treated animals and were stimulated with LPS in the presence of inhibitors of p38 (SB 202190) and ERK1/2 (PD 98059). The presence of SB 202190 (10 µM) and PD 98059 (50 µM), at doses that did not affect the cell viability, significantly reduced IL-6 production by macrophages, regardless of ethanol exposure (Fig. 6 ). At 100 ng/ml LPS, the effectiveness of SB 202190 or PD 98059 was comparable, with a reduction of IL-6 levels of 60–65%. Macrophages from ethanol-treated mice, cultured in the presence of SB 202190 or PD 98059, showed a trend toward further reduction of IL-6 production (70–80%). However, a difference between SB 202190 or PD 98059 effects on IL-6 synthesis by macrophages from saline or ethanol-treated mice never reached a statistical significance. Thus, the magnitude of inhibition of macrophage-derived IL-6 by SB 202190 or PD 98059 corresponded with the inhibitory effect of ethanol treatment alone. The inclusion of both inhibitors led to more than 90% reduction of IL-6 levels in all tested macrophage groups, indicating that p38 and ERK1/2 are crucial in LPS-stimulated IL-6 production. SB 202190 and PD 98059 are considered selective inhibitors of p38 and ERK1/2, respectively, although they have been shown to inhibit additional protein kinase activities [37 ]. Thus, the involvement of other than p38 and ERK1/2 protein kinases in IL-6 production cannot be excluded. However, the results of other studies showing overlapping, inhibitory activities were obtained in a cell-free system, and additional evidence suggests that in cell-based experiments, some protein kinase inhibitors, among them PD 98059, may be more potent and target-specific [43 ].



View larger version (18K):
[in this window]
[in a new window]
 
Figure 6. Effects of ethanol and inhibitors of p38 (SB 202190) and ERK1/2 (PD 98059) MAPK on LPS-induced IL-6 production by macrophages, which were isolated from mice 24 h after the administration of ethanol or saline (control) was cultured for 16 h with or without 100 ng/ml LPS in the absence or presence of specific p38 (SB 202190) and/or ERK1/2 (PD 98059) inhibitors. Supernatants were collected and assayed for IL-6 content. IL-6 was not detected in supernatants from unstimulated cultures. Eight animals per group were analyzed. ANOVA, followed by Fisher’s LSD test, was applied to compare values among multiple groups. *, P < 0.01, from all other groups; **, P < 0.01, from control and ethanol groups with both inhibitors present.


arrow
DISCUSSION
 
Multiple reports indicate that acute ethanol exposure inhibits proinflammatory cytokine production in response to the infectious challenge [13 14 15 , 17 ]. We chose to measure IL-6 production as an indicator of inflammatory response, as this cytokine is crucial in stimulation of acute-phase response, and its elevation is considered to be a major risk factor in the development of the cardiovascular disease [44 ] and in a poor outcome following traumatic injury [45 ]. In this study, we showed that acute, moderate dose of ethanol inhibited macrophage-inflammatory responses, as exemplified by a lower capacity of murine macrophages to produce IL-6 after 3 h and 24 h post-ethanol exposure. Not surprisingly, 24 h after the treatment, ethanol could no longer be detected in the circulation; therefore, the inhibitory effect persisted in the absence of ethanol. Others have shown synergistic, inhibitory effects of resveratrol and ethanol on LPS-stimulated, 24-h, IL-6 production by murine macrophages [46 ]. However, in that study, all the agents were added in vitro to the murine peritoneal macrophages activated by thioglycollate.

To address the question of a mechanism behind the ethanol-induced impairment of IL-6 production, we hypothesized that ethanol may affect macrophage inflammatory responses by alterations in the activation of p38 and ERK1/2 MAPK. We showed that ethanol administration down-regulated p38 and ERK1/2 phosphorylation levels in macrophages stimulated by adherence to polystyrene or by activation with LPS. Moreover, LPS-induced IL-6 synthesis was reduced in the presence of p38 or ERK1/2 inhibitors (SB 202190 and PD 98059, respectively), indicating that IL-6 production triggered by LPS involves p38 and ERK1/2 activation. The effectiveness of SB 202190 or PD 98059 in a reduction of IL-6 synthesis was comparable with a degree of ethanol-induced inhibition. Moreover, neither of the inhibitors significantly exacerbated ethanol-mediated suppression of IL-6 production, suggesting that the ethanol exposure could affect p38 and ERK1/2 activation.

It is important that the ability of p38 and ERK1/2 to respond to the LPS stimulation was not abolished by ethanol. We observed LPS-triggered up-regulation of phosphorylation of both MAPK in macrophages from ethanol-exposed mice, although their activation levels remained below the control group. These results indicated that the ability of p38 and ERK1/2 to respond to the LPS stimulation was not abolished by ethanol. Rather, it is plausible that phosphorylation levels of p38 and ERK1/2 in ethanol-treated groups remained lower than control, as a result of the ethanol-related, initial down-regulation in a baseline activation of both enzymes.

In contrast to p38 and ERK1/2 down-regulation, ethanol administration had no effect on the basal levels of phosphorylated I{kappa}B. Similarly, it has been reported that ethanol administration did not change I{kappa}B phosphorylation levels in human monocytes [33 ].

Numerous observations link acute and chronic ethanol exposure with the opposing effects on proinflammatory cytokine production. Inhibition accompanies acute ethanol exposure [16 , 17 ], and augmentation was reported following chronic ethanol administration [10 11 12 ]. Similarly, acute and chronic ethanol treatments appear to have opposing effects on phosphorylation levels of p38 and ERK1/2. Our studies show inhibition of p38 and ERK1/2 MAPK in response to in vivo acute ethanol treatment. These data are in accord with a report that in vitro exposure of human peripheral blood mononuclear cells to ethanol leads to a reduction of LPS-induced p38 phosphorylation [47 ]. In contrast, liver macrophages (Kupffer cells) from rats fed with ethanol for several weeks displayed an increase in p38 and ERK1/2 phosphorylation levels upon LPS stimulation [12 , 48 ]. The similar, opposing effects of acute and chronic ethanol exposure on proinflammatory cytokine production could then parallel the similar, opposing effects of ethanol on activation of p38 and ERK1/2.

It was reported that the inflammatory response seen in human peripheral blood monocytes, as exemplified by the levels of LPS-stimulated IL-1ß synthesis, was down-regulated 16 h after ethanol consumption [16 ]. Similarly, our study indicates that an inhibitory effect of ethanol on IL-6 production was still present 24 h after ethanol exposure. This diminished cytokine production was accompanied by a down-regulation of p38 and ERK1/2. Moreover, the examination of IL-6 production and p38 and ERK1/2 phosphorylation levels 48 h after ethanol administration showed that the ethanol effect was transient, as at this time point, baseline levels of p38 and ERK1/2 activation and LPS-stimulated IL-6 synthesis returned to the control levels.

The observation that reduced IL-6 production was accompanied by a decrease in p38 and ERK1/2 activity suggests that the intracellular mechanism of the ethanol inhibitory effect can involve impairment in p38 and ERK1/2 activation. In a number of studies, ethanol is considered to exert a modulatory effect on signal-transduction pathways, including suppression of NF-{kappa}B activation [33 ] and inhibition of inositol triphosphate production [49 ]. It was also suggested that ethanol may shorten the half-life of phosphorylated signal-transduction molecules by activation of phosphotyrosine phosphatase [50 ]. Moreover, inhibitors of phosphotyrosine and phosphoserine/phosphothreonine phosphatases were shown to activate ERK1/2 and stimulate IL-8 production in an HL-60 human promyelocytic cell line [51 ]. It is interesting that p38 and ERK1/2 can be inactivated by MAPK phosphatase-1 (MKP-1) [52 53 54 ]. Ethanol may up-regulate MKP-1, which could in turn result in an increased rate of p38 and ERK1/2 dephosphorylation, leading to a down-regulation of both MAPKs. Thus, lower activation levels of p38 and ERK1/2 could explain the reduced production of IL-6. Additional evidence in support of this scenario was provided by the experiments with p38 and ERK1/2 inhibitors. A reduction of LPS-stimulated IL-6 production by macrophages cultured in the presence of SB 202190 and PD 98059 indicates that p38 and ERK1/2 are a part of the LPS-induced signaling cascade leading to IL-6 synthesis.

Growing evidence indicates the importance of p38 in T helper cell type 1 differentiation and cytokine production. It is then possible that the mechanism behind polarization of immune response from type 1 toward type 2 by ethanol [16 , 55 , 56 ] could be explained by ethanol-induced impairment of p38 activation.

It is worth noting that although excessive consumption of ethanol has been linked to the higher susceptibility to infectious diseases [9 ], there are multiple reports indicating benefits of moderate consumption of alcohol [57 ]. The major effect of moderate alcohol use is linked to a reduction of the risk for coronary heart disease [58 ] and stroke [59 ]. As there is also growing evidence that inflammation is a contributing factor in the etiology of these diseases, it is plausible to consider that a positive effect of ethanol on the cardiovascular system may result from its anti-inflammatory action. It is interesting that moderate use of ethanol rather than abstinence, has been associated with lower serum levels of IL-6 and lower risk for cardiovascular disease [60 ]. Therefore, from the clinical perspective, it is of critical importance to understand the mechanism(s) behind the immunomodulatory effects of ethanol. This, in clinical practice, could allow one to mimic the benefits and counteract detriments of ethanol use.


arrow
ACKNOWLEDGEMENTS
 
NIH R01 AA12034, R01 AA12034-S1, and T32 AA13527 and Illinois Excellence in Academic Medicine grants supported this work.


arrow
FOOTNOTES
 
1 Current address: Center for Surgical Research & Department of Surgery, University of Alabama at Birmingham, Volker Hall G 094, 1670 University Boulevard, Birmingham, AL 35294-0019. Back

Received July 25, 2003; revised October 1, 2003; accepted October 28, 2003.


arrow
REFERENCES
 
    1
  1. Messingham, K. A. N., Faunce, D. E., Kovacs, E. J. (2002) Alcohol, injury, and cellular immunity Alcohol 28,137-149[CrossRef][Medline]
  2. 2
  3. Germann, G., Barthold, U., Lefering, R., Raff, T., Gartmann, B. (1997) The impact of risk factors and pre-existing conditions on the mortality of burn patients and the precision of predictive admission scoring systems Burns 23,195-203[CrossRef][Medline]
  4. 3
  5. Faunce, D. E., Gregory, M. S., Kovacs, E. J. (1997) Effects of acute ethanol exposure on cellular immune responses in a murine model of thermal injury J. Leukoc. Biol. 62,733-740[Abstract]
  6. 4
  7. Nolan, J. P. (1965) Alcohol as a factor in the illness of university service patients Am. J. Med. Sci. 249,135-142[Medline]
  8. 5
  9. Ruiz, M., Ewig, S., Torres, A., Arancibia, F., Marco, F., Mensa, J., Sanchez, M., Martinez, J. A. (1999) Severe community-acquired pneumonia. Risk factors and follow-up epidemiology Am. J. Respir. Crit. Care Med. 160,397-405[Abstract/Free Full Text]
  10. 6
  11. Khan, K. N., Yatsuhashi, H. (2000) Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients Alcohol Alcohol 35,286-295[Abstract/Free Full Text]
  12. 7
  13. Wiese, J. G., Shlipak, M. G., Browner, W. S. (2000) The alcohol hangover Ann. Intern. Med. 132,897-902[Abstract/Free Full Text]
  14. 8
  15. Szabo, G. (1999) Consequences of alcohol consumption on host defense Alcohol Alcohol 34,830-841[Abstract/Free Full Text]
  16. 9
  17. Nelson, S., Kolls, J. K. (2002) Alcohol, host defense and society Nat. Rev. Immunol. 2,205-209[CrossRef][Medline]
  18. 10
  19. Deviere, J., Content, J., Denys, C., Vandenbussche, P., Schandene, L., Wybran, J., Dupont, E. (1989) High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production Clin. Exp. Immunol. 77,221-225[Medline]
  20. 11
  21. Khoruts, A., Stahnke, L., McClain, C. J., Logan, G. J., Allen, I. (1991) Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients Hepatology 13,267-276[CrossRef][Medline]
  22. 12
  23. Kishore, R., Hill, J. R., McMullen, M. R., Frenkel, J., Nagy, L. E. (2002) ERK1/2 and Eg-1 contribute to increased TNF-{alpha} production in rat Kupffer cells after chronic ethanol feeding Am. J. Physiol. Gastrointest. Liver Physiol. 282,G6-G15[Abstract/Free Full Text]
  24. 13
  25. Nelson, S., Bagby, G. J., Bainton, B. G., Summer, W. R. (1989) The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response J. Infect. Dis. 160,422-429[Medline]
  26. 14
  27. Verma, B. K., Fogarasi, M., Szabo, G. (1993) Down-regulation of tumor necrosis factor {alpha} activity by acute ethanol treatment in human peripheral blood monocytes J. Clin. Immunol. 13,8-22[CrossRef][Medline]
  28. 15
  29. Szabo, G., Mandrekar, P., Newman, L., Catalano, D. (1996) Regulation of human monocyte functions by acute ethanol treatment: decreased TNF{alpha}, IL-1ß and elevated IL-10, TGFß production Alcohol. Clin. Exp. Res. 20,900-907[Medline]
  30. 16
  31. Szabo, G. (1998) Monocytes, alcohol use, and altered immunity Alcohol. Clin. Exp. Res. 22,216S-219S[CrossRef][Medline]
  32. 17
  33. Boe, D. M., Nelson, S., Zhang, P., Bagby, G. J. (2001) Acute ethanol intoxication suppresses lung chemokine production following infection with Streptococcus pneumoniae J. Infect. Dis. 184,1134-1142[CrossRef][Medline]
  34. 18
  35. Girouard, L., Mandrekar, P., Catalano, D., Szabo, G. (1998) Regulation of monocyte interleukin-12 production by acute alcohol: a role for inhibition by interleukin-10 Alcohol. Clin. Exp. Res. 22,211-216[CrossRef][Medline]
  36. 19
  37. Waltenbaugh, C., Peterson, J. D. (1997) Ethanol impairs the induction of delayed hypersensitivity in C57BL/6 mice Alcohol 14,149-153[CrossRef][Medline]
  38. 20
  39. Peterson, J. D., Herzenberg, L. A., Vasquez, K., Waltenbaugh, C. (1998) Glutathione levels in antigen presenting cells modulate Th1 versus Th2 response patterns Proc. Natl. Acad. Sci. USA 95,3071-3076[Abstract/Free Full Text]
  40. 21
  41. Dong, C., Davis, R. J., Flavell, R. A. (2002) MAP kinases in the immune response Annu. Rev. Immunol. 20,55-72[CrossRef][Medline]
  42. 22
  43. Han, J., Ulevitch, R. J. (1999) Emerging targets for anti-inflammatory therapy Nat. Cell Biol. 1,E39-E40[CrossRef][Medline]
  44. 23
  45. Schaeffe, H. J., Weber, M. J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers Mol. Cell. Biol. 19,2435-2444[Free Full Text]
  46. 24
  47. Dumitru, C. D., Ceci, J. D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J. H., Patriotis, C., Jenkins, N. A., Copeland, N. G., Kollias, G., Tsichlis, P. N. (2000) TNF-{alpha} induction by LPS is regulated posttranscriptionally via Tpl2/ERK-dependent pathway Cell 103,1071-1083[CrossRef][Medline]
  48. 25
  49. Johnson, G. L., Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases Science 298,1911-1912[Abstract/Free Full Text]
  50. 26
  51. Guha, M., Mackman, N. (2001) LPS induction of gene expression in human monocytes Cell. Signal 13,85-94[CrossRef][Medline]
  52. 27
  53. Sweet, M. J., Hume, D. A. (1996) Endotoxin signal transduction in macrophages J. Leukoc. Biol. 60,8-26[Abstract]
  54. 28
  55. Lu, H. T., Yang, D. D., Wysk, M., Gatti, E., Mellman, I., Davis, R. J., Flavell, R. A. (1999) Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice EMBO J. 18,1845-1857[CrossRef][Medline]
  56. 29
  57. Doherty, T. M. (1995) T-cell regulation of macrophage function Curr. Opin. Immunol. 7,400-404[CrossRef][Medline]
  58. 30
  59. Russell, D. G. (1995) Of microbes and macrophages: entry, survival and persistence Curr. Opin. Immunol. 7,479-484[CrossRef][Medline]
  60. 31
  61. Carter, A. B., Knudtson, K. L., Monick, M. M., Hunninghake, G. W. (1999) The p38 mitogen-activated protein kinase is required for NF-{kappa}B-dependent gene expression. The role of TATA-binding protein (TBP) J. Biol. Chem. 274,30858-30863[Abstract/Free Full Text]
  62. 32
  63. Carter, A. B., Hunninghake, G. W. (2000) A constitutive active MEK -> ERK pathway negatively regulates NF-{kappa}B-dependent gene expression by modulating TATA-binding protein phosphorylation J. Biol. Chem. 275,27858-27864[Abstract/Free Full Text]
  64. 33
  65. Mandrekar, P., Catalano, D., Szabo, G. (1999) Inhibition of lipopolysaccharide-mediated NF{kappa}B activation by ethanol in human monocytes Int. Immunol. 11,1781-1790[Abstract/Free Full Text]
  66. 34
  67. Fontanilla, C. V., Faunce, D. E., Gregory, M. S., Messingham, K. A., Durbin, E. A., Duffner, L. A., Kovacs, E. J. (2000) Anti-interleukin-6 antibody treatment restores cell-mediated immune function in mice with acute ethanol exposure before burn trauma Alcohol. Clin. Exp. Res. 24,1392-1399[CrossRef][Medline]
  68. 35
  69. Messingham, K. A., Fontanilla, C. V., Colantoni, A., Duffner, L. A., Kovacs, E. J. (2000) Cellular immunity after ethanol exposure and burn injury: dose and time dependence Alcohol 22,35-44[CrossRef][Medline]
  70. 36
  71. Faunce, D. E., Gregory, M. S., Kovacs, E. J. (1998) Acute ethanol exposure prior to thermal injury results in decreased T-cell responses mediated in part by increased production of IL-6 Shock 10,135-140[Medline]
  72. 37
  73. Davies, S. P., Reddy, H., Caivano, M., Cohen, P. (2000) Specificity and mechanism of action of some commonly used proteine kinase inhibitors Biochem. J. 351,95-105[CrossRef][Medline]
  74. 38
  75. Choudhry, M. A., Uddin, S., Sayeed, M. M. (1998) Prostaglandin E2 modulation of p59fyn tyrosine kinase in T lymphocytes during sepsis J. Immunol. 160,929-935[Abstract/Free Full Text]
  76. 39
  77. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227,680-685[CrossRef][Medline]
  78. 40
  79. Burnette, W. N. (1981) "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A Anal. Biochem. 112,195-203[CrossRef][Medline]
  80. 41
  81. Fuhlbrigge, R. C., Chaplin, D. D., Kiely, J. M., Unanue, E. R. (1987) Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide J. Immunol. 138,3799-3802[Abstract]
  82. 42
  83. Bauer, G. J., Arbabi, S., Garcia, I. A., deHingh, I., Rosengart, M. R., Maier, R. V., Bauer, G. J., Arbabi, S., Garcia, I. A., deHingh, I., Rosengart, M. R., Maier, R. V. (2000) Adherence regulates macrophage signal transduction and primes tumor necrosis factor production Shock 14,435-440[Medline]
  84. 43
  85. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., Saltiel, A. R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo J. Biol. Chem. 270,27489-27494[Abstract/Free Full Text]
  86. 44
  87. McCarty, M. F. (1999) Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline Med. Hypotheses 52,465-477[CrossRef][Medline]
  88. 45
  89. Faist, E. (1996) The mechanisms of host defense disfunction following shock and trauma Curr. Top. Microbiol. Immunol. 216,259-274[Medline]
  90. 46
  91. Feng, Y. H., Zou, J. P., Li, X. Y. (2002) Effects of resveratrol and ethanol on production of pro-inflammatory factors from endotoxin activated murine macrophages Acta Pharmacol. Sin. 23,1002-1006[Medline]
  92. 47
  93. Arbabi, S., Garcia, I., Bauer, G. J., Maier, R. V. (1999) Alcohol (ethanol) inhibits IL-8 and TNF: role of the p38 pathway J. Immunol. 162,7441-7445[Abstract/Free Full Text]
  94. 48
  95. Cao, Q., Mak, K. M., Lieber, C. S. (2002) Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-{alpha} generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-{kappa}B Biochem. Biophys. Res. Commun. 294,849-853[CrossRef][Medline]
  96. 49
  97. Fano, G., Belia, S., Mariggio, M. A., Antonica, A., Agea, A., Spinozzi, F. (1993) Alteration of membrane transductive mechanisms induced by ethanol in human lymphocyte cultures Cell. Signal 5,139-143[CrossRef][Medline]
  98. 50
  99. Ostrovidov, S., Howard, L. M., Ikeda, M., Ikeda, A., Waltenbaugh, C. (2002) Restoration of ethanol-compromised Th1 responses by sodium orthovanadate Int. Immunol. 14,1239-1245[Abstract/Free Full Text]
  100. 51
  101. Sonoda, Y., Kasahara, T., Yamaguchi, Y., Kuno, K., Matsushima, K., Mukaida, N. (1997) Stimulation of interleukin-8 production by okadaic acid and vanadate in human promyelocyte cell line, an HL-60 subline J. Biol. Chem. 272,15366-15372[Abstract/Free Full Text]
  102. 52
  103. Franklin, C. C., Kraft, A. S. (1997) Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells J. Biol. Chem. 272,16917-16923[Abstract/Free Full Text]
  104. 53
  105. Brondello, J. M., Brunet, A., Pouyssegur, J., McKenzie, F. R. (1997) The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade J. Biol. Chem. 272,1368-1376[Abstract/Free Full Text]
  106. 54
  107. Xaus, J., Comalada, M., Valledor, A. F., Cardo, M., Herrero, C., Soler, C., Lloberas, J., Celada, A. (2001) Molecular mechanisms involved in macrophage survival, proliferation, activation and apoptosis Immunobiology 204,543-550[CrossRef][Medline]
  108. 55
  109. Schodde, H., Hurst, S., Munroe, M., Barrett, T., Waltenbaugh, C. (1996) Ethanol injestion inhibits cell-mediated immune responses of unprimed T-cell receptor transgenic mice Alcohol. Clin. Exp. Res. 20,890-899[Medline]
  110. 56
  111. Latif, O., Peterson, J. D., Waltenbaugh, C. (2002) Alcohol-mediated polarization of type 1 and type 2 immune responses Front. Biosci. 7,a135-a147[Medline]
  112. 57
  113. Klatsky, A. L. (2003) Drink to your health? Sci. Am. 288,74-81[Medline]
  114. 58
  115. Klatsky, A. L. (1994) Epidemiology of coronary heart disease—influence of alcohol Alcohol. Clin. Exp. Res. 18,88-96[CrossRef][Medline]
  116. 59
  117. Reynolds, K., Lewis, L. B., Nolen, J. D., Kinney, G. L., Sathya, B., He, J. (2003) Alcohol consumption and risk of stroke: a meta-analysis J. Am. Med. Assoc. 289,579-588[Abstract/Free Full Text]
  118. 60
  119. Bermudez, L. E., Wu, M., Martinelli, J., Young, L. S. (1991) Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages Lymphokine Cytokine Res. 10,413-419[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Szabo, A. Dolganiuc, Q. Dai, and S. B. Pruett
TLR4, Ethanol, and Lipid Rafts: A New Mechanism of Ethanol Action with Implications for other Receptor-Mediated Effects
J. Immunol., February 1, 2007; 178(3): 1243 - 1249.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. H. Lau, M. Abe, and A. W. Thomson
Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo
J. Leukoc. Biol., May 1, 2006; 79(5): 941 - 953.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. B. Pruett, Q. Zheng, C. Schwab, and R. Fan
Sodium Methyldithiocarbamate Inhibits MAP Kinase Activation through Toll-like Receptor 4, Alters Cytokine Production by Mouse Peritoneal Macrophages, and Suppresses Innate Immunity
Toxicol. Sci., September 1, 2005; 87(1): 75 - 85.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Goral and E. J. Kovacs
In Vivo Ethanol Exposure Down-Regulates TLR2-, TLR4-, and TLR9-Mediated Macrophage Inflammatory Response by Limiting p38 and ERK1/2 Activation
J. Immunol., January 1, 2005; 174(1): 456 - 463.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0703350v1
75/3/553    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goral, J.
Right arrow Articles by Kovacs, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goral, J.
Right arrow Articles by Kovacs, E. J.